Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Available NCT07906093

Expanded Access Program to Provide STC-15 to Patients With Selected Advanced Cancer

Conditions: Cancer

Sex: All
Ages: 12 Years – N/A
Sponsor: STORM Therapeutics LTD

Summary

This Expanded Access Program (EAP) is intended to provide access to STC-15 outside of a clinical study setting for adult and adolescent patients with serious or life-threatening malignancies who, in the opinion of their treating physician, may benefit from treatment with STC-15, have no satisfactory alternative therapeutic options available, are not eligible for or cannot reasonably access an ongoing STC-15 clinical trial within a clinically appropriate timeframe, and meet the eligibility criteria described in this protocol.

Eligibility Criteria

Inclusion Criteria: 1. Adult patients aged ≥18 years, or pediatricadolescent patients aged 12 to \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07906093). StuddyBuddy aggregates publicly available trial information.